EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical characteristics and outcomes in CMV infection in intestinal transplant recipients: A single‐center experience

Anmary A Fernandez iD, Jacques Simkins iD, Shweta Anjan iD, Lilian Abbo iD, Gennaro Selvaggi, Vighnesh Venkatasamy, Rafael Miyashiro, Eric Martin, Joshua Turkeltaub, Leopold Arosemena, Christopher O'Brien, Akin Tekin und 6 weitere

Transplant Infectious Disease · 2023

DOI: 10.1111/tid.14071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Anmary A Fernandez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Associates of Tampa Bay, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Intestines, Transplant Recipients, Organ Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytomegalovirus (CMV) infection is one of the most common posttransplantation infections and has been associated with increased rejection and mortality. Data in intestinal transplants recipients are limited.

Methods

This is a single‐center, retrospective cohort study of all intestinal transplants performed between January 1, 2009, and August 31, 2020. We included recipients of all ages who were at risk of CMV infection. To identify the risk factors, we conducted at first univariate and multivariate analysis. For the multivariate analysis, we developed a logistic regression model based on the result of univariate analysis.

Results

Ninety five patients with a median age of 32 (interquartile range [IQR] 4, 50) were included. CMV donor seropositive/recipient seronegative were 17 (17.9%). Overall, 22.1% of the recipients developed CMV infection at a median time of 155 (IQR 28–254) days from transplant, including 4 CMV syndrome and 6 CMV end‐organ disease. Overall, 90.4%, (19/21) developed DNAemia while on prophylaxis. Median peak viral load and time to negativity was 16 000 (IQR 1034–43 892) IU/mL and 56 (IQR 49–109) days, respectively. (Val)ganciclovir and foscarnet were utilized in 17 (80.9%) and 1 (4.76%) recipients, respectively. Recurrences of CMV DNAemia and graft rejection were observed in three and six recipients, respectively. Younger age was identified as a risk factor ( p = .032, odds ratio 0.97, 95% confidence interval 0.95–0.99) to develop CMV DNAemia.

Conclusion

A significant proportion of intestinal transplant recipients developed CMV infection while on prophylaxis. Better methods such as CMV cell mediated immunity guided prophylaxis should be used to prevent infections in this population. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsIntestinesTransplant RecipientsOrgan TransplantationHumansRetrospective StudiesMaleFemaleAdultMiddle AgedRisk FactorsAntiviral AgentsCytomegalovirusViral LoadChild, PreschoolGraft RejectionChildAdolescentYoung AdultFoscarnet

Stichwörter der Autor:innen

cytomegalovirusimmunosuppressionintestinal transplantmulti-visceral transplantsolid organ transplant

Substanzen

Antiviral AgentsFoscarnet

Autor:innen und Institutionen

  • Infectious Disease Associates of Tampa Bay, Tampa, Florida, USA.
  • Miami Transplant Institute, Jackson Health System, Miami, Florida, USA.
  • Department of Medicine, Division of Infectious Disease, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Medicine, Division of Hepatology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Pharmacy, Jackson Health System, Miami, Florida, USA.

ORCID-Profile: Anmary A Fernandez, Jacques Simkins, Shweta Anjan, Lilian Abbo, Rodrigo M Vianna, Yoichiro Natori

Zitieren

APA

Fernandez, A. A., Simkins, J., Anjan, S., Abbo, L., Selvaggi, G., Venkatasamy, V., Miyashiro, R., Martin, E., Turkeltaub, J., Arosemena, L., O'Brien, C., Tekin, A., Vega, A., Perez, M. M., Kelly, J. J., Garcia, J., Vianna, R. M., & Natori, Y. (2023). Clinical characteristics and outcomes in CMV infection in intestinal transplant recipients: A single‐center experience. Transplant Infectious Disease. https://doi.org/10.1111/tid.14071

Vancouver

Fernandez AA, Simkins J, Anjan S, Abbo L, Selvaggi G, Venkatasamy V, et al. Clinical characteristics and outcomes in CMV infection in intestinal transplant recipients: A single‐center experience. Transplant Infectious Disease. 2023. doi:10.1111/tid.14071

BibTeX
@article{Fernandez2023,
  author = {Fernandez, Anmary A and Simkins, Jacques and Anjan, Shweta and Abbo, Lilian and Selvaggi, Gennaro and Venkatasamy, Vighnesh and Miyashiro, Rafael and Martin, Eric and Turkeltaub, Joshua and Arosemena, Leopold and O'Brien, Christopher and Tekin, Akin and Vega, Ana and Perez, Michelle M and Kelly, Jennifer Jebrock and Garcia, Jennifer and Vianna, Rodrigo M and Natori, Yoichiro},
  title = {Clinical characteristics and outcomes in CMV infection in intestinal transplant recipients: A single‐center experience},
  journal = {Transplant Infectious Disease},
  year = {2023},
  doi = {10.1111/tid.14071}
}
Kostenlos starten →